BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Tacrolimus Binding Protein 1a

Below is an extended Tacrolimus Binding Protein 1a research listing. Click here to return to the Tacrolimus Binding Protein 1a main in depth entry.

Recent Publications on Tacrolimus Binding Protein 1a:

FK506-binding protein (FKBP12) regulates ryanodine receptor-evoked Ca2+ release in colonic but not aortic smooth muscle.
In smooth muscle, the ryanodine receptor (RyR) mediates Ca(2+) release...
Direct Link
6th September, 2008
Division of Physiology and Pharmacology, Strathclyde Institute of Pharmacy
FK506 binding protein 12 differentially accelerates fibril formation of wild type alpha-synuclein and its clinical mutants A30P or A53T.
Aggregation of alpha-synuclein (alpha-SYN) plays a key role in Parkinson's...
Direct Link
20th August, 2008
Laboratory of Biomolecular Dynamics, K. U. Leuven, Flanders, Belgium.
Conditional transgenesis using Dimerizable Cre (DiCre).
Cre recombinase is extensively used to engineer the genome of experimental...
Direct Link
9th August, 2008
ICNE-UMR 6544 Centre National de Recherche Scientifique (CNRS), Universite
A new pharmacologic action of CCI-779 involves FKBP12-independent inhibition of mTOR kinase activity and profound repression of global protein synthesis.
The mammalian target of rapamycin (mTOR) inhibitor CCI-779 (temsirolimus)...
Direct Link
11th June, 2008
Discovery Oncology, Wyeth Research, Pearl River, NY 10965, USA.
Endoplasmic reticulum Ca2+ measurements reveal that the cardiac ryanodine receptor mutations linked to cardiac arrhythmia and sudden death alter the threshold for store-overload-induced Ca2+ release.
A number of RyR2 (cardiac ryanodine receptor) mutations linked to...
Direct Link
22nd May, 2008
Department of Physiology and Biophysics, University of Calgary, Calgary,
RyR1-specific requirement for depolarization-induced Ca2+ sparks in urinary bladder smooth muscle.
Ryanodine receptor subtype 1 (RyR1) has been primarily characterized in...
Direct Link
6th May, 2008
CNRS UMR 5017, Laboratoire de Signalisation et Interactions Cellulaires,
Nuclear magnetic resonance fragment-based identification of novel FKBP12 inhibitors.
Peptidyl-prolyl cis-trans isomerases are a group of cytosolic enzymes...
Direct Link
4th April, 2008
Infectious and Inflammatory Disease Center, Burnham Institute for Medical
Neointimal expression of rapamycin receptor FK506-binding protein FKBP12: postinjury animal and human in-stent restenosis tissue characteristics.
Despite excellent clinical results for sirolimus (rapamycin)-eluting...
Direct Link
18th March, 2008
Department of Internal Medicine II - Cardiology, University of Bonn, Bonn,
Requirements for peptidyl-prolyl isomerization activity: a comprehensive mutational analysis of the substrate-binding cavity of FK506-binding protein 12.
Peptidyl-prolyl isomerase (PPIase) activity is exhibited by many proteins...
Direct Link
12th February, 2008
Laboratory of Structural Biology, School of Biomedical Science, Tokyo
[A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase] 25th January, 2008
Distinctive expression and functional regulation of the maize (Zea mays L.) TOR kinase ortholog.
TOR (Target of rapamycin) kinase is a central component of a signal...
Direct Link
25th January, 2008
Departamento de Bioquimica, Facultad de Quimica, UNAM, Ciudad
Overexpression of FK-506 binding protein 12.0 modulates excitation contraction coupling in adult rabbit ventricular cardiomyocytes.
The effect of the 12-kDa isoform of FK-506-binding protein (FKBP)12.0 on...
Direct Link
14th December, 2007
Department of Cardiology and Pneumology, Georg-August-University
Accurate and efficient corrections for missing dispersion interactions in molecular simulations.
In simulations, molecular dispersion interactions are frequently neglected...
Direct Link
7th December, 2007
Department of Chemistry, Columbia University, New York, New York 10027,
Cell signaling. mTOR, unleashed.
Peptidyl-prolyl isomerase (PPIase) activity is exhibited by many proteins...
Direct Link
6th December, 2007
Department of Biochemistry and Molecular Biology, University of British
Increased striatal mRNA and protein levels of the immunophilin FKBP-12 in experimental Parkinson's disease and identification of FKBP-12-binding proteins.
FKBP-12, a 12 kDa FK506-binding protein (neuroimmunophilin), acts as a...
Direct Link
6th December, 2007
Laboratory for Biological and Medical Mass Spectrometry, Uppsala
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional